Latest news with #CRISP
Scottish Sun
2 days ago
- Health
- Scottish Sun
I used to scoff 4 bags of crisps a day, couldn't walk up stairs & was 20st – now I'm half the size without fat jabs
Plus, how people treat her differently now she has lost weight WEIGH TO GO I used to scoff 4 bags of crisps a day, couldn't walk up stairs & was 20st – now I'm half the size without fat jabs A CRISP addict who ballooned to 20 stone scoffing down four bags a day managed to lose half her body weight naturally - without using any jabs. Lisa Bernett, 44, tipped the scales at a whopping 20st 5lbs at her heaviest and found herself struggling to even get up the stairs. 9 Lisa Bernett, 44, reached 20st 5lbs thanks to her crisp and takeaway addiction Credit: SWNS 9 She has now shed 10st 5lbs without weight loss jabs Credit: SWNS She would gorge on entire grab bags of Doritos crisps, two takeaways a week costing £50 a week as well as eating "huge" portions of cheesy pasta. But after Lisa's husband told her he wanted to lose weight, she decided to follow suit as she didn't want to be bigger than him. Having previously tried the "fad" diets without success, Lisa instead decided to use a calorie app MyNetDiary instead of weight loss jabs like Mounjaro. And within two years she had slimmed down from a size 24 dress to a svelte size 8 after shedding 10st 5lbs all by changing her diet and exercising. More on weight loss JABS UP Can you get free fat jabs on the NHS? The 4 key criteria plus exact weight revealed Lisa, from Boreham Wood, Hertfordshire, said: " I would never used the jabs as I do not believe it teaches you about fat loss or educating yourself about food. "It's a good tool to have but if you have no other tools then how will you keep it off? "There's no way I would want to stay on injections for the rest of my life in the fear that if I stop I'll gain. "I also didn't feel comfortable going down the surgery route." Lisa, who runs a funeral directors, added: "When my husband said he wanted to lose weight that set the bells of. "I didn't want him to be smaller than me, I'm quite old fashioned and I thought 'if he's smaller me than he can't protect me.' "My lifestyle before was pretty bad - I didn't move. I look unrecognisable after my 14st weight loss - it's like my partner has brand new girlfriend "I'd take the kids to school, go to work and then come home and sit on my backside. "Walking, going up the stairs, it was hard. "My knees hurt and I got out of breath really quickly. "Thankfully, I never had any health issues, but I got chest infections quite a lot." 9 She used to gorge on entire grab bags of Doritos crisps, two takeaways a week, and eat 'huge' portions of cheesy pasta Credit: SWNS 9 She has slimmed down from a size 24 dress to a svelte size 8 Credit: SWNS After deciding to make a change, Lisa knew she had to address her diet. She said the calorie counting app allowed her to still maintain her bigger portions, whilst prioritising protein and fibre. She switched the heavy cheesy pasta for jacket potato with grilled chicken and salad and soon began to notice a change. Combined with an exercise regime of an initial 10,000 steps a day - upped to 20,000 - and regular gym activity, Lisa managed to shed the pounds. She is now able to pick "anything" off the clothing rack in a store after previously 'hating' shopping. FOOD BEFORE Lisa said: "My diet was poor. I wouldn't ever eat breakfast. "Lunchtime I'd either eat loads of pasta with cheese, or I'd have lots of bagels with cheese. "For a snack I'd have a whole bag of crisps with a dip - I didn't realise a whole bag of and a dip was probably my whole daily allowance for food. "I'd have a takeaway twice a week and big portions of home cooked meals. "I always had to finish my plates. 9 Lisa used to struggle to go up stairs Credit: SWNS 9 She said the calorie counting app allowed her to still maintain her bigger portions, whilst prioritising protein and fibre Credit: SWNS "Now, I use a calorie app. "I reeducated myself about food and now I know when I'm going to lose weight and when I'm not. "My portions are big but they're big with calorie dense food. "I priorities my protein goal, fibre goal and a calorie goal. "As long as I hit these goals then it doesn't matter about my fat and carbs. "As soon as you cut out food, your body wants it. "When people say they're going to have 1,200 calories, it's not sustainable and then you binge over the weekend." 9 She switched the heavy cheesy pasta for jacket potato with grilled chicken and salad and soon began to notice a change Credit: SWNS LISA DIET: BEFORE AND AFTER LISA'S BEFORE DIET Breakfast: None Lunch: Big portion of cheesy pasta Snack: Crisp grab bags Dinner: Home cooked big portion or takeaway LISA'S DIET NOW Breakfast: 60 grams of porridge, 28g vanilla protein powder, 200ml almond milk, 80g blueberries Lunch: potato, 300g tuna in brine, tin of sweetcorn, 50g spring onion and mix with 50ml lite mayo, 20ml balsamic vinegar. Dinner: Jacket potato 300g, bowl of salad, spring onions, beetroot and balsamic vinegar, with grilled chicken and peri peri salt. FITNESS CHANGE She also incorporated a gym routine into her new lifestyle - despite previously "running out crying" as she thought everyone was looking at her before eventually conquering her fears. Lisa said: "I started off with walking 10,000 steps a day. I did that for three months but now I'm doing 20,000 a day. "I got a gym membership, and I walked in and it was so overwhelming. "You feel like everyone's looking at you and I ran out crying. "So I got a PT, and I had him for three or four months. 9 Now she feels fully confident in a bikini on holiday Credit: SWNS "I liked the boxing part of it so I started Muay Thai which I did three times a week - sometimes five times a week. "Now I'm at another place where I have gym sessions and do martial arts every morning. "I do that Monday, Wednesday and Friday, then on Tuesday and Thursday I go to gym and do weights." CHANGED OPINIONS Despite all her success, Lisa says since losing the weight people around her have "changed." She explained: "A lot of people didn't think I'd stick to it, and I get that as I'd probably think the same thing. "I know there are other people who are waiting for me to put the weight back on. "People change when you lose weight. 9 She does exercise every day to help her weight loss Credit: SWNS "I'm not that fat friend anymore and everyone likes to have a fat friend. "Strangers are also nicer to me. "I used to hide in the back in photos, now I want to be in the front - I love it. "I eat properly during the week so I know I can have a big plate of food at a restaurant on Saturday, and I don't feel like people are watching or judging me, but if I was big, they'd be judging me." Lisa said her advice for others who are looking to do the same is to "take accountability." She added: "Not everyone's perfect. "Even on the days you find hard, and you want to reach out for something bad, do it, but weigh it and take accountability, then rein it back in the following day."
The Hindu
26-06-2025
- Business
- The Hindu
Karnataka extends AEDP in BCom to 85 govt. colleges effective 2025-26
In response to increased demand from students, Karnataka has extended the Apprenticeship-Embedded Degree Programmes (AEDP) in BCom courses to 85 government first-grade colleges across the State for the 2025-26 academic year. In addition, the paid apprenticeship, which was limited to the 6th semester earlier for AEDP programmes, has been extended to the fifth semester as well. To provide job opportunities to students, the Higher Education Department had launched four new AEDPs in 45 government first grade colleges in 21 districts in the 2024-25 academic year. The four new degree programmes are BCom in retail, logistics, e-commerce, banking, finance, service, and insurance. How it works Under this programme, students will pursue a regular college education in the first and second year and undergo apprenticeship training with companies in their final year. The students will get a stipend from ₹8,000 to ₹18,000 depending upon capability. The curriculum is provided by the Centre for Research in Schemes and Policies (CRISP) and approved by the board of studies of universities. 'This time, there was a high demand from students for AEDP courses, and colleges were demanding enhancement of these courses. In this context, orders have been issued to start these courses in 85 colleges this year after discussing with the government. Around 50,000 students will benefit,' said Manjushree N., commissioner, Collegiate Education and Technical Education Department. Demand for Arts courses This time, there is a huge demand for degree courses in government first-grade colleges, and a total of 26,923 seats have been enhanced by the College Education Department. Out of this, there was a higher demand for Arts courses, and a total of 13,905 seats have been increased, officials said. As many as 4,856 seats were enhanced for BSc degree and 4,130 seats for 516 for BBA, 2,841 for BCA, 495 for BSW and 180 for other courses. The increase in seats for BBA and BCA courses has been allowed subject to approval from All India Council For Technical Education (AICTE). It has been suggested that teaching of BCA courses should be done on shift basis in colleges where there is a shortage of computers.
Time of India
19-06-2025
- Business
- Time of India
Moving beyond SMART goals: The emergence of CRISP goals in strategic leadership, ETHRWorld
Performance Management 4 min read Moving beyond SMART goals: The emergence of CRISP goals in strategic leadership In boardrooms and team huddles worldwide, SMART goals—Specific, Measurable, Achievable, Relevant, Time-bound—have long been the gold standard for driving performance. But in today's hyper-dynamic business landscape, critics argue that SMART falls short; it is too narrow to spark ambition, too rigid to adapt, and often too transactional to inspire. Enter CRISP goals—a fresh framework designed to inject challenge, robustness, inspiration, strategy and rigorous planning into every target we set. The article introduces the CRISP framework—Challenging, Robust, Inspirational, Strategic, and Planned—as a forward-thinking alternative that addresses modern leadership and organizational needs. By analysing the limitations of SMART goals and demonstrating the advantages of CRISP goals, it highlights why companies must adopt a more visionary and resilient approach to goal-setting.
Yahoo
03-06-2025
- Business
- Yahoo
Gene Editing Market Research Report 2025-2029 - Biotech Leaders Drive Innovation as Gene Editing Becomes Key to Sustainable Solutions
Gene editing technologies like CRISPR are revolutionizing biotechnology, expanding from medical applications to diverse industries. Initially used for altering genes in human cells to cure previously uncurable diseases, they are now paving the way for rapid growth and new industrial applications. Discover the emerging opportunities, near and long-term expectations, and growth potential through comprehensive research that empowers you as an expert in your field. Complimentary additional data is available. Dublin, June 03, 2025 (GLOBE NEWSWIRE) -- The "Gene Editing Markets 2025-2029 by Application, Technology, Place, Industry and Product with Executive & Consultant Guides" report has been added to offering. This comprehensive view of the gene editing landscape highlights the technology's potential to drive transformative change. As breakthroughs become more frequent, businesses need to stay informed about the latest trends and projections. Those equipped with thorough market insights are poised to leverage these technologies effectively, ensuring competitive advantages in their respective fields. Gene Editing is moving from strength to strength. CRISPR and similar tools are finding new uses in every area of biotechnology. It started with Medical applications by changing genes in living human cells. Uncurable diseases have already being cured. More are on the way. The market for gene editing tools is witnessing a surge, with rapid growth driven by technological advances. These tools are broadening their reach beyond healthcare, offering groundbreaking possibilities in agriculture, biofuel production, and more. Major players in the biotechnology industry are spearheading research to develop innovative applications, ensuring continual market evolution. Industry experts indicate that the gene editing industry is set to continue its rapid expansion. Companies and researchers are actively investigating diverse opportunities in areas such as crop improvement, pest control, and sustainable resource management. These developments position gene editing as a cornerstone technology, promising significant impacts on global food security and sustainable practices. The gene editing market is becoming increasingly sophisticated, with new applications and technologies emerging regularly. As demand for more precise and efficient biotechnological solutions grows, the sector continues to attract substantial investment. Key players are focusing on research and development, strengthening their market positions, and pushing forward innovations to meet both current needs and future challenges. Key Topics Covered: 1 Market Guides1.1 Strategic Situation Analysis1.2 Guide for Executives, Marketing, Sales and Business Development Staff1.3 Guide for Management Consultants and Investment Advisors2 Introduction and Market Definition2.1 Methodology2.1.1 Methodology2.1.2 Sources2.1.3 Authors2.2 What is Gene Editing?2.3 The CRISPR Example2.3.1 What is CRISPR?2.3.2 The CRISPR Family2.4 Chromosomes, Genes and Epigenetics2.4.1 Chromosomes2.4.2 Genes2.4.3 Epigenetics2.5 Market Definition2.5.1 Revenue Market Size2.6 Perspective: Healthcare Spending2.6.1 Global Healthcare Spending2.6.2 Spending on Healthcare and Pharmaceuticals2.6.3 Spending on Diagnostics2.6.4 Important Role of Insurance for Medical Services3 Market Structure3.1 Market Structure Therapeutics3.1.1 Research and Development (R&D) Companies3.1.2 Biotechnology Companies3.1.3 Generic Drug Manufacturers3.1.4 Big Pharmaceuticals3.1.5 Contract Research Organizations (CROs)3.1.6 Contract Manufacturing Organizations (CMOs)3.1.7 Specialty Pharmaceutical Companies3.1.8 Pharmaceutical Distributors3.1.9 Retail Pharmacies3.1.10 Wholesalers3.1.11 Online Pharmacies3.1.12 Health Technology Companies3.1.13 Pharmacy Benefit Managers (PBMs)3.1.14 Clinical Laboratories3.1.15 Medical Device Companies3.1.16 Regulatory Bodies3.2 Market Structure Diagnostics3.2.1 Academic Research Lab3.2.2 Diagnostic Test Developer3.2.3 Instrumentation Supplier3.2.4 Chemical/Reagent Supplier3.2.5 Pathology Supplier3.2.6 Independent Clinical Laboratory3.2.7 Public National/regional Laboratory3.2.8 Hospital Laboratory3.2.9 Physicians Office Lab (POLS)3.2.10 Audit Body3.2.11 Certification Body4 Market Trends4.1 Factors Driving Growth4.1.1 Cell Therapy4.1.2 Gene Therapy4.1.3 The New Agriculture4.1.4 Genetics and Cell Metabolism4.2 Factors Limiting Growth4.2.1 The Cost Curve4.2.2 Time and Trials4.2.3 The Price Barrier5 Recent Developments in Gene Editing5.1 Recent Developments - Importance and How to Use This Section5.1.1 Importance of These Developments5.1.2 How to Use This Section5.2 CRISPR tool allows for remote-controlled gene-editing5.3 CRISPR Making Sweeter Tomatoes5.4 Researchers Create gene-edited prawns5.5 Gene Editing Corrects Cystic Fibrosis5.6 CRISPR gene editing to change healthcare?5.7 CrisprBits Collaborates With MolBio Diagnostics5.8 Sherlock Bioscience to Launch Free AI-Based Operating System5.9 Sherlock Biosciences to Acquire Sense Biodetection5.10 CRISPR Enzyme Discovery Opens New Applications5.11 Sherlock Biosciences Adds Ambient Amplification to Toolkit5.12 Rice University Adapts CRISPR Enzyme5.13 Princeton Group Develops Cas13 Assay for Point-of-Care Use5.14 Proof Dx Plans Infectious Disease, Oncology Tests for CRISPR-Based POC System5.15 Sherlock Biosciences Raises $80M5.16 Broad Institute Considers CRISPR Respiratory Panels to Replace PCR5.17 Medix Biochemica Acquires MyPols Biotec5.18 Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets EUA5.19 Genome Diagnostics Makes €1M Investment in Scope Biosciences5.20 CRISPR Test Could be used for Asymptomatic Screening5.21 Mammoth Biosciences, Agilent to Comarket CRISPR-Based SARS-CoV-2 Test5.22 Pandemic Accelerates Development of CRISPR Diagnostics5.23 ERS Genomics Licenses CRISPR Patents to Vivlion5.24 Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test5.25 ERS Genomics, FASMAC to Commercialize CRISPR-Cas95.26 The Nobel Prize in Chemistry 2020 - CRISPR Wins6 Key Companies6.1 10x Genomics, Inc.6.2 4D Molecular Therapeutics6.3 Abeona Therapeutics6.4 Acrigen Biosciences6.5 Adarx Pharmaceuticals6.6 Adverum Biotechnologies6.7 Affini-T Therapeutics6.8 Agilent6.9 Arbor Biotechnologies6.10 Arcturus Therapeutics6.11 Axxam6.12 Beam Therapeutics6.13 Beckman Coulter Diagnostics (Danaher)6.14 Becton, Dickinson and Company6.15 Binx Health6.16 bioMerieux Diagnostics6.17 Bio-Rad Laboratories, Inc.6.18 Bluebird Bio6.19 Caribou Biosciences6.20 Cell Microsystems6.21 Cellenion (BICO)6.22 Century Therapeutics6.23 Chroma Medicine6.24 Creative Biogene6.25 Crispr Therapeutics6.26 Editas Medicine6.27 ERS Genomics6.28 FASMAC6.29 Genscript Biotech6.30 Illumina6.31 Inscripta6.32 Intellia Therapeutics6.33 J&J Innovative Medicine6.34 Locus Biosciences6.35 Mammoth Biosciences6.36 Metagenomi6.37 Myllia Biotechnology6.38 Namocell6.39 NRGene6.40 Poseida Therapeutics6.41 Precision Biosciences6.42 Prime Medicine6.43 Proof Diagnostics6.44 Regeneron Pharmaceuticals6.45 Revvity6.46 Roche Diagnostics6.47 Sherlock Biosciences6.48 Thermo Fisher Scientific6.49 Twist Bioscience6.50 Verve Therapeutics6.51 Vivlion6.52 Wave Life Science7 The Global Market for Gene Editing7.1 Global Market Overview by Country7.2 Global Market by Application - Overview7.3 Global Market Technology - Overview7.4 Global Market Type - Overview7.5 Global Market Industry - Overview7.6 Global Market Product - Overview8 Gene Editing Markets - By Application8.1 Cell Line8.2 Plant8.3 Animal8.4 Cell Therapy8.5 Gene Therapy8.6 Diagnostics8.7 Research9 Global Gene Editing Markets - by Technology9.1 Crispr9.2 Talens9.3 ZFN9.4 Meganuclease10 Gene Editing Markets - by Place10.1 In Vivo10.2 Ex Vivo10.3 In Vitro11 Gene Editing Markets - by Industry11.1 Pharma11.2 Clinical11.3 Academic11.4 Contract12 Global Gene Editing Markets - by Product12.1 Instruments12.2 Cells12.3 Reagents13 Appendices13.1 United States Medicare System: laboratory Fees Schedule13.2 The Most Used IVD Assays13.3 The Highest Grossing Assays13.4 The Whole Genome Sequence of SARS-CoV-213.5 Global Listing of Sequencing Establishments - Location & Contacts For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Associated Press
25-04-2025
- Business
- Associated Press
High Value Acquisition Completed to Substantially Strengthen Operations Structure and Seasoned Leadership of Advanced Video Compression Tech Company: Reticulate Micro, Inc. (Symbol: RMXI)
$RMXI Proprietary Platform Delivers High-Impact Results in Ultra-Low-Bandwidth Environments, Enabling Real-Time Video Where Traditional Solutions Fail Reticulate Micro, Inc. (OTCQB: RMXI) is a video technology company focused on addressing the world's growing crisis in video data transmission and storage. Through its proprietary VAST (Video Adaptive Systems Technology) platform, RMXI is aiming to transform how organizations capture, transmit, store and share visual data. The Company's battle-tested technology, proven in military applications, reduces video bandwidth, storage, and power consumption by up to 50% while maintaining quality across any network or hardware platform. From defense to AI and enterprise applications, RMXI endeavors to redefine how organizations handle the growing demands of video data worldwide. Reticulate Micro's 2024 was defined by rapid technological advancements and rigorous market validation of its flagship VAST platform. Originally developed for government and defense applications, RMXI VAST delivered high-impact results in ultra-low-bandwidth environments, enabling real-time video where traditional solutions fail. Multiple military exercises and test events (over 20 in 2024) have proven RMXI VAST's ability to stream video on any communication band, including narrow-band SATCOM, L-Band and even legacy HF networks where streaming video was thought to be unviable. Building on its success in tactical video solutions for defense applications, RMXI is expanding its enterprise-level offerings for government and commercial customers. RMXI plans to release significant platform enhancements in early 2025, including advanced dynamic bandwidth management and adaptive encoding capabilities. Additionally, through its commercial joint venture launching in Q1 2025, RMXI is positioned to bring its revolutionary technology to global commercial markets. The RMXI 2025 strategy centers on partner-focused growth and a platform-centric product roadmap: Government Sector Partnership & OEM Integration Strategic Partner Program: RMXI is launching a comprehensive integration program enabling partners and system integrators to embed VAST technology directly into their product lines and existing government contract vehicles. Major Exercises & Evaluations: VAST has already been validated within U.S. Special Operations, multiple U.S. Army and Naval initiatives, and a range of international defense programs. This year's schedule includes high-profile exercises with U.S. SOCOM, Army, and Navy, as well as several invitations specifically created for VAST testing and evaluation. Commercial Scale via Joint Venture (RMX and CRISP) Global Managed Services: RMXI partnered with K2 Endeavor DMCC to form RMX, a joint venture company building upon VAST and branded as 'CRISP' (Compressed Rate Intelligent Streaming Protocol) for commercial and enterprise verticals—from telecommunications to security camera networks. Recurring Revenue Model: RMX's global managed service structure is designed to offer predictable, long-term revenue while solving critical video-delivery challenges for enterprise customers. Expanded Product Suite VAST Video Encoder: The core software-based video encoder product will see the addition of key features including audio, KLV metadata support, video tele-conferencing, and region of interest encoding. VAST Vue: Cross-platform (Windows, Linux, Mac OS, Android, iOS) video player for seamless end-to-end experiences, including support for tactical metadata. VAST SDK: Development tools and APIs for advanced integration of core VAST capabilities into partner products and solutions. VAST VUDO: An advanced combination of VAST's video streaming capabilities with advanced mapping and sensor data integration to provide enhanced situational awareness in disconnected and austere environments. VAST Cloud: VAST-as-a-Service cloud offering for enterprise solutions, including live streaming, transcoding and VOD (video on demand) services. Acquisition of Remaining RMX Industries Inc. Shares to Consolidate Operations and Expand Leadership Team On April 23rd RMXI announced that it has acquired the remaining shares of RMX Industries Inc., the Company's 50/50 joint venture company with K2 Endeavor DMCC, through a stock exchange transaction, making it a wholly-owned subsidiary. The move consolidates operations and aligns resources to accelerate commercial business opportunities across key sectors. As part of this strategic consolidation, RMXI also announced important changes to its governance and management teams: Kirchof has been appointed as an independent member of the RMXI board of directors. Mr. Kirchof has over 20 years of experience building entrepreneurial companies and driving innovation in healthcare technology. Mr. Kirchof is the CEO of CureGrail, Inc., a healthcare technology company engaging and empowering patients to own and manage their disease, and founder and CEO of RxPath, LLC, a healthcare transaction company. Mr. Kirchof previously co-founded Matrix Oncology and served in executive, sales management, marketing, and strategy leadership positions at iKnowMed, Inc., MedStat Group, and IBM Healthcare. Karl Kit has been appointed as RMXI Chief Executive Officer, President and as a member of the board of directors. Mr. Kit is a seasoned entrepreneur with over 40 years of international business experience across advertising, communications, mobile data services, and financial technology. Mr. Kit previously headed K2 Endeavor DMCC, a UAE-based strategic investment group. Andrew Sheppard has been appointed as President of RMX Government. Mr. Sheppard will lead RMXI efforts in the defense and government sectors, focusing on deploying its cutting-edge video and data compression technologies to meet the mission-critical needs of military and public safety customers. Mr. Sheppard previously served as the Company's Chief Executive Officer and President. Maxwell Kit has been appointed as RMXI Chief Marketing Officer. Mr. Kit has extensive experience in global brand strategy, digital engagement, and go-to-market execution. As CMO, he will lead RMX's marketing and communications efforts, refine the RMXI brand identity, and expand market visibility. Mr. Kit will oversee the launch of integrated campaigns that highlight the transformative power of RMXI proprietary compression technology across defense, AI, telecommunications, and enterprise sectors. Opening of VAST Research & Testing Facility On March 17th RMXI announced the opening of its state-of-the-art VAST Research & Testing Facility (VRTF) outside of Rochester, NY. The facility covers dozens of acres and is capable of hosting real-life scenarios involving various tactical radio communication networks with manned/unmanned vehicles. RMXI expects the facility to accelerate the adoption of VAST's video compression technology by government programs and facilitate its uptake by tactical communications network vendors. VAST is a groundbreaking software-based video encoder platform, the first ever able to stream video over HF radio. Unlike traditional video encoder systems, VAST can operate on most x86 or Arm computing platform – from servers to low-SWaP (size, weight, and power) single-board computers. Its ability to enable video in bandwidth and resource-constrained tactical networks has opened a myriad of opportunities for video applications in scenarios and use cases where they were previously impossible. VAST Partner Program On March 3rd RMXI announced plans for its VAST Partner Program. The program will facilitate technology vendors and solution integrators to incorporate VAST's groundbreaking video compression technology into their products and offerings. The RMXI VAST Partner Program will include a dedicated partner manager who works closely with participants throughout the integration to commercialization process. Partners will receive engineering toolkits, demonstration resources, and technical consulting to accelerate time-to-market. The program will also offer early access to new features, input into product roadmaps, and collaborative marketing opportunities. Importantly, the program is available to all qualified companies interested in exploring VAST's capabilities. For more information on $RMXI visit DISCLAIMER: Disclosure listed on the CorporateAds website Media Contact Company Name: Reticulate Micro, Inc. Contact Person: Reticulate Micro Media Relations Email: Send Email Phone: 866-70 MICRO Address:4220 Duncan Ave, Suite 201 City: St. Louis State: Missouri 63110 Country: United States Website: Source: CAP, LLC
